Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 568-572

  Tse, Gary M K ^a   Ma, Tony K F ^b   Chu, Winnie C W ^a   Lam, Wynnie W M ^a   Poon, Cycles S P ^c   Chan, Wing Cheong ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

^c NORTH DISTRICT HOSPITAL   (Hong Kong)

Author keywords

Breast; Mucinous carcinoma; Neuroendocrine

Indexed keywords

CHROMOGRANIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MUCIN; NEURON SPECIFIC ENOLASE; PROGESTERONE RECEPTOR; SYNAPTOPHYSIN;

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER MORTALITY; CELL DIFFERENTIATION; CELL NUCLEUS; CLINICAL FEATURE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MUCINOUS CARCINOMA; NEUROENDOCRINE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, NEUROENDOCRINE; CELL DIFFERENTIATION; CHROMOGRANINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCINS; PHOSPHOPYRUVATE HYDRATASE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 3042848450     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800092     Document Type: Article

References (13)

1. Page DL, Sakamoto G. Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ (eds). Diagnostic Histopathology of the Breast. Churchill Livingstone; Edinburgh, 1987, pp 206-210.
2. Pinder SE, Elston CW, Ellis IO. Invasive carcinomausual histological types. In: Elston CW, Ellis IO (eds). Systemic Pathology, Vol. 13, 3rd edn. Churchill Livingstone; Edinburgh, 1998, pp 315-319.
3. Rosen PP. Mucinous carcinoma. In: Rosen's Breast Pathology, 2nd edn. Lippincott Williams & Wilkins; Philadelphia, PA, 2001, pp 463-481.
4. Capella C, Eusebi V, Mann B, et al. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980;4:613-630.
5. Rasmussen BB, Rose C, Thorpe SM, et al. Argyrophilic cells in 202 human mucinous breast carcinomas. Am J Clin Pathol 1985;84:737-740.
6. Coady AT, Shousha S, Dawson PM, et al. Mucinous carcinoma of the breast: further characterization of its three subtypes. Histopathology 1989;15:617-626.
7. Scopi L, Andreola S, Pilotti S, et al. Mucinous carcinoma of the breast. A clinicopathologic, histochemical and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol 994;18:702-711.
8. Kato N, Endo Y, Tamura G, et al. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation. Pathol Int 1999;49:947-955.
9. Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: form of low grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996;20:921-943.
10. Maluf HM, Koerner FC. Carcinomas of the breast with endocrine differentiation: a review. Virchows Arch 1994;425:449-457.
11. Azzopardi JG, Muretto P, Goddeeris P, et al. 'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology 1982;6: 549-569.
12. Fisher ER, Palekar A. Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol 1979;72:909-916.
13. Honma N, Sakamoto G, Akiyama F, et al. Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen, and progesterone receptor status. Histopathology 2003;42: 120-127.